Premier (PINC)
(Delayed Data from NSDQ)
$18.37 USD
-0.13 (-0.70%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $18.36 -0.01 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
B Value C Growth B Momentum B VGM
Premier, Inc. (PINC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$21.89 | $30.00 | $18.00 | 18.32% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Premier, Inc. comes to $21.89. The forecasts range from a low of $18.00 to a high of $30.00. The average price target represents an increase of 18.32% from the last closing price of $18.50.
Analyst Price Targets (9 )
Broker Rating
Premier, Inc. currently has an average brokerage recommendation (ABR) of 2.90 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 2.90 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, one is Strong Buy, representing 10% of all recommendations. A month ago, Strong Buy represented 10%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/PINC.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 8 | 8 | 8 | 7 | 6 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.90 | 2.90 | 2.90 | 2.89 | 2.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/8/2024 | Robert W. Baird & Co. | Eric W Coldwell | Hold | Hold |
5/8/2024 | Piper Sandler | Jessica E Tassan | Hold | Hold |
5/8/2024 | UBS | Kevin Caliendo | Not Available | Hold |
5/8/2024 | Canaccord Genuity | Richard Close | Strong Buy | Hold |
2/26/2024 | SVB Securities | Michael Cherny | Not Available | Hold |
1/3/2024 | Not Identified | Not Identified | Not Available | Hold |
11/10/2023 | The Benchmark Company | William Sutherland | Strong Buy | Strong Buy |
9/18/2023 | Guggenheim Securities | Jack D Wallace | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.90 |
ABR (Last week) | 2.90 |
# of Recs in ABR | 10 |
Average Target Price | $21.89 |
LT Growth Rate | 1.50% |
Industry | Medical Services |
Industry Rank by ABR | 88 of 252 |
Current Quarter EPS Est: | 0.49 |